Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma

Brachytherapy

Volumn 6, Issue 3, 2007, Pages 218-226

  Oehler Jänne, Christoph ^a   Seifert, Burkhardt ^b   Lütolf, Urs M ^a   Studer, Gabriela ^a   Glanzmann, Christoph ^a   Ciernik, I Frank ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

Anal cancer; Anal carcinoma; Brachytherapy; Chemoradiation; Radiation therapy

Indexed keywords

IRIDIUM 192; MITOMYCIN C;

ADJUVANT THERAPY; ADULT; AGED; ANUS CARCINOMA; ANUS SPHINCTER; ARTICLE; BRACHYTHERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN TOXICITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANUS NEOPLASMS; BRACHYTHERAPY; CARCINOMA; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34547501643     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.02.152     Document Type: Article

References (30)

1. Ortholan C., Ramaioli A., Peiffert D., et al. Anal canal carcinoma: Early-stage tumors < or =10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 479-485
2. Chauveinc L., Buthaud X., Falcou M.C., et al. Anal canal cancer treatment: Practical limitations of routine prescription of concurrent chemotherapy and radiotherapy. Br J Cancer 89 (2003) 2057-2061
3. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
4. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
5. Gerard J.P., Ayzac L., Hun D., et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 46 (1998) 249-256
6. Doci R., Zucali R., Bombelli L., et al. Combined chemoradiation therapy for anal cancer. A report of 56 cases. Ann Surg 215 (1992) 150-156
7. John M., Flam M., and Palma N. Ten-year results of chemoradiation for anal cancer: Focus on late morbidity. Int J Radiat Oncol Biol Phys 34 (1996) 65-69
8. Papillon J., and Montbarbon J.F. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 30 (1987) 324-333
9. Papillon J., Montbarbon J.F., Gerard J.P., et al. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int J Radiat Oncol Biol Phys 17 (1989) 1161-1169
10. Pizzi G.B., and Marchetti C. Brachytherapy with pulsed dosage. General considerations. Radiobiological considerations. First clinical experience in Mestre (Venice). Radiol Med (Torino) 93 (1997) 260-266
11. Kapp K.S., Geyer E., Gebhart F.H., et al. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 49 (2001) 997-1005
12. Vordermark D., Flentje M., Sailer M., et al. Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life. Strahlenther Onkol 177 (2001) 252-258
13. Sandhu A.P., Symonds R.P., Robertson A.G., et al. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: Ten years experience. Int J Radiat Oncol Biol Phys 40 (1998) 575-581
14. 192Ir implantation: A 10-year experience. Brachytherapy 3 (2004) 95-100
15. Dubois J.B., Azria D., and Ychou M. External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: A series of 70 patients. Bull Cancer 90 (2003) 1107-1110
16. Peiffert D., Bey P., Pernot M., et al. Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys 39 (1997) 57-66
17. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
18. Papillon J., Montbarbon J.F., Gerard J.P., et al. Radionecrosis after curietherapy for anal carcinoma. Current methods of radiation therapy (author's transl). Gastroenterol Clin Biol 3 (1979) 193-198
19. Allal A.S., Sprangers M.A., Laurencet F., et al. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 80 (1999) 1588-1594
20. Broens P., Van Limbergen E., Penninckx F., et al. Clinical and manometric effects of combined external beam irradiation and brachytherapy for anal cancer. Int J Colorectal Dis 13 (1998) 68-72
21. Vordermark D., Sailer M., Flentje M., et al. Curative-intent radiation therapy in anal carcinoma: Quality of life and sphincter function. Radiother Oncol 52 (1999) 239-243
22. Allal A.S., Mermillod B., Roth A.D., et al. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 1099-1105
23. Milano M.T., Jani A.B., Farrey K.J., et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63 (2005) 354-361
24. Oehler-Janne C., Seifert B., Lutolf U.M., et al. Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. Radiat Oncol 1 (2006) 29
25. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
26. Williams J., Chen Y., Rubin P., et al. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 182-188
27. Berger C., Felix-Faure C., Chauvet B., et al. Conservative treatment of anal canal carcinoma with external radiotherapy and interstitial brachytherapy, with or without chemotherapy: Long-term results. Cancer Radiother 3 (1999) 461-467
28. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348 (1996) 1049-1054
29. Cummings B.J., Keane T.J., O'Sullivan B., et al. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
30. Papillon J. Rectal and anal cancers (1982), Springer Verlag, Heidelberg